Forward Pharma’s Journey & LEO Foundation as a Strategic Owner

📍 Open to all NPLG members.
Join us for the NPLG Fall Event & Networking Dinner on 10 September 2025 for two captivating talks from leaders in Danish life sciences.

Claus Bo Svendsen will walk us through Forward Pharma’s exceptional journey and its billion-dollar license deal with Biogen, while Peter Kjeldsen Hansen will introduce us to the LEO Foundation, the journey from sole ownership to potential IPO of LEO Pharma and how they exercise engaged ownership.

Claus Bo Svendsen

Founder, S21 Advisory | Former CEO, Forward Pharma

Claus led Forward Pharma - one of Denmark’s most remarkable biopharma journeys. As a seasoned biotech executive and advisor, Claus brings firsthand insights into high-stakes dealmaking, value creation in IP-heavy biotechs, and lessons from steering a public company.

Peter Kjeldsen Hansen

Vice President, Head of Strategic Ownership, LEO Foundation

Peter oversees strategic ownership at the LEO Foundation, with a focus on long-term value creation and active engagement as a majority owner. At NPLG, he will offer a rare look into the foundation ownership model, the transition toward IPO readiness, and how strategic foundations navigate governance, influence, and legacy building in pharma.

🗓 Agenda

• 16:45 Welcome drinks

• 17:00 Forward Pharma presentation

• 18:00 LEO Foundation presentation

• 19:15 Networking dinner (venue TBD) - sign up for dinner using the below link

(Wine courtesy of NPLG; dinner at member’s own expense)

📍 Want to become a member of NPLG? Read more on www.nplg.eu

Location & Parking: The event takes place at Gorrissen Federspiel, Axel Towers, Copenhagen. Parking is available in the basement of Axel Towers.

Sign up for dinner using this link:

Soon to come

Host or Publisher Nordic Pharma Licensing Group